Chemoprevention with low-dose aspirin, mesalazine, or both in patients with familial adenomatous polyposis without previous colectomy (J-FAPP Study IV): a multicentre, double-blind, randomised, two-by-two factorial design trial-Reference-Cited by-同舟云学术

Chemoprevention with low-dose aspirin, mesalazine, or both in patients with familial adenomatous polyposis without previous colectomy (J-FAPP Study IV): a multicentre, double-blind, randomised, two-by-two factorial design trial

Published:2021-06 Issue:6 Volume:6 Page:474-481
ISSN:2468-1253
Container-title:The Lancet Gastroenterology & Hepatology
language:en
Short-container-title:The Lancet Gastroenterology & Hepatology

Author:

Ishikawa Hideki,Mutoh Michihiro,Sato Yasushi,Doyama Hisashi,Tajika Masahiro,Tanaka Shinji,Horimatsu Takahiro,Takeuchi Yoji,Kashida Hiroshi,Tashiro Jun,Ezoe Yasumasa,Nakajima Takeshi,Ikematsu Hiroaki,Hori Shinichiro,Suzuki Sadao,Otani Takahiro,Takayama Tetsuji,Ohda Yoshio,Mure Kanae,Wakabayashi Keiji,Sakai Toshiyuki

Funder

Japan Agency for Medical Research and Development

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference24 articles.

1. A clinical overview of familial adenomatous polyposis derived from the database of the Polyposis Registry of Japan;Iwama;Int J Clin Oncol,2004

2. Adverse effects of sulindac used for prevention of colorectal cancer;Ishikawa;J Natl Cancer Inst,1997

3. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis;Steinbach;N Engl J Med,2000

4. Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention;Solomon;N Engl J Med,2005

5. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial;Bresalier;N Engl J Med,2005

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dynamics of the gut microbiome in FAP patients undergoing intensive endoscopic reduction of polyp burden;Gut;2024-08-01

2. Gastrointestinal Cancer Precursor Conditions and Their Detection;Hematology/Oncology Clinics of North America;2024-08

3. Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets;Signal Transduction and Targeted Therapy;2024-06-19

4. Current management of familial adenomatous polyposis;Expert Review of Anticancer Therapy;2024-05-26

5. Updated European guidelines for clinical management of familial adenomatous polyposis (FAP), MUTYH-associated polyposis (MAP), gastric adenocarcinoma, proximal polyposis of the stomach (GAPPS) and other rare adenomatous polyposis syndromes: a joint EHTG-ESCP revision;British Journal of Surgery;2024-05